Clinical trial
A Prospective, Multicenter, Randomized Controlled, Noninferiority Clinical Trial Evaluating the Safety and Efficacy of Sirolimus-coated Coronary Balloon Dilatation Catheter for the Treatment of De Novo Coronary Artery Small Vessel Lesions.
NCT06345209 is registered in ClinicalTrials.gov with BrosMed Medical Co., Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicenter, Randomized Controlled, Noninferiority Clinical Trial Evaluating the Safety and Efficacy of Sirolimus-coated Coronary Balloon Dilatation Catheter for the Treatment of De Novo Coronary Artery Small Vessel Lesions.
- Lead sponsor
- BrosMed Medical Co., Ltd
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- May 31, 2024
- Completion date
- December 31, 2025
- Enrollment
- 236 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.